Public Profile

Valeant Farmaceutica Do Brasil Ltda

Valeant Farmacêutica do Brasil Ltda, a prominent player in the pharmaceutical industry, is headquartered in Brazil and operates extensively across the South American region. Founded in the early 2000s, the company has established itself as a leader in the development and distribution of innovative healthcare solutions, focusing on dermatology, ophthalmology, and neurology. With a diverse portfolio of prescription medications and over-the-counter products, Valeant is recognised for its commitment to quality and efficacy. The company has achieved significant milestones, including strategic partnerships and acquisitions that have bolstered its market position. Valeant Farmacêutica do Brasil Ltda continues to strive for excellence, making substantial contributions to the healthcare landscape while prioritising patient needs and advancing medical science.

DitchCarbon Score

How does Valeant Farmaceutica Do Brasil Ltda's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Valeant Farmaceutica Do Brasil Ltda's score of 33 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

62%

Let us know if this data was useful to you

Valeant Farmaceutica Do Brasil Ltda's reported carbon emissions

Valeant Farmaceutica Do Brasil Ltda currently does not have available carbon emissions data, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete data, it is essential to note that many pharmaceutical companies are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprints. However, without specific information from Valeant, it is unclear what initiatives or commitments they may have in place regarding carbon emissions and climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Valeant Farmaceutica Do Brasil Ltda's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Valeant Farmaceutica Do Brasil Ltda is in BR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Valeant Farmaceutica Do Brasil Ltda is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers